Endosomal crosstalk: Meeting points for signaling pathways

Trends in Cell Biology

Volumn 22, Issue 9, 2012, Pages 447-456

  Pálfy, Máté ^a   Reményi, Attila ^a   Korcsmáros, Tamás ^a,b  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITIDE; PROTEIN CCNE1; PROTEIN GRB1; PROTEOME; SCAFFOLD PROTEIN; SMAD ANCHOR FOR RECEPTOR ACTIVATION; SONIC HEDGEHOG PROTEIN; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

BINDING AFFINITY; ENDOCYTOSIS; ENDOSOME; HUMAN; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOSOMES; HUMANS; PROTEIN BINDING; PROTEIN ENGINEERING; SIGNAL TRANSDUCTION;

EID: 84865599600     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.06.004     Document Type: Review

References (88)

1. Wiley H.S., et al. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 1991, 266:11083-11094.
2. Bo S.K., et al. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 1997, 322:1-18.
3. Miaczynska M., et al. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 2004, 16:400-406.
4. Howe C.L., Mobley W.C. Signaling endosome hypothesis: a cellular mechanism for long distance communication. J. Neurobiol. 2004, 58:207-216.
5. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 2005, 6:112-126.
6. Polo S., Di Fiore P.P. Endocytosis conducts the cell signaling orchestra. Cell 2006, 124:897-900.
7. Howe C.L. Modeling the signaling endosome hypothesis: why a drive to the nucleus is better than a (random) walk. Theor. Biol. Med. Model. 2005, 15:1-15.
8. Taelman V.F., et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010, 143:1136-1148.
9. Dobrowolski R., De Robertis E.M. Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat. Rev. Mol. Cell Biol. 2011, 13:53-60.
10. Shilo B.-Z., Schejter E.D. Regulation of developmental intercellular signalling by intracellular trafficking. EMBO J. 2011, 30:3516-3526.
11. Zeke A., et al. Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol. 2009, 19:364-374.
12. Nada S., et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J. 2009, 28:477-489.
13. Teis D., et al. p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J. Cell Biol. 2006, 175:861-868.
14. Stasyk T., et al. Proteomic analysis of endosomes from genetically modified p14/MP1 mouse embryonic fibroblasts. Proteomics 2010, 10:4117-41127.
15. Sancak Y., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
16. Panopoulou E., et al. Early endosomal regulation of Smad-dependent signaling in endothelial cells. J. Biol. Chem. 2002, 277:18046-18052.
17. Chen Y.-G., et al. Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-beta signaling. J. Biol. Chem. 2007, 282:9688-9695.
18. Bhattacharyya R.P., et al. Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 2006, 75:655-680.
19. Papin J.A., et al. Reconstruction of cellular signalling networks and analysis of their properties. Nat. Rev. Mol. Cell Biol. 2005, 6:99-111.
20. Luo W., Lin S.-C. Axin: a master scaffold for multiple signaling pathways. Neurosignals 2004, 13:99-113.
21. Abell A.N., et al. MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3β. J. Biol. Chem. 2007, 282:30476-30484.
22. Cliffe A., et al. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr. Biol. 2003, 13:960-966.
23. Bilic J., et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007, 316:1619-1622.
24. Furuhashi M., et al. Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway. Mol. Cell. Biol. 2001, 21:5132-5141.
25. Schenck A., et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 2008, 133:486-497.
26. Nazarewicz R.R., et al. Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin ii-induced, PKC-α-dependent Akt activation in endosomes. J. Biol. Chem. 2011, 286:2886-2895.
27. Miura S., Mishina Y. Hepatocyte growth factor-regulated tyrosine kinase substrate (Hgs) is involved in BMP signaling through phosphorylation of smads and TAK1 in early mouse embryo. Dev. Dyn. 2011, 240:2474-2481.
28. Pires-daSilva A., Sommer R.J. The evolution of signalling pathways in animal development. Nat. Rev. Genet. 2003, 4:39-49.
29. Gerhart J. 1998 Warkany lecture: signaling pathways in development. Teratology 1999, 60:226-239.
30. Fraser I.D.C., Germain R.N. Navigating the network: signaling cross-talk in hematopoietic cells. Nat. Immunol. 2009, 10:327-331.
31. Natarajan M., et al. A global analysis of cross-talk in a mammalian cellular signalling network. Nat. Cell Biol. 2006, 8:571-580.
32. Robinson G.W. Cooperation of signalling pathways in embryonic mammary gland development. Nat. Rev. Genet. 2007, 8:963-972.
33. Fisher J., et al. Predictive modeling of signaling crosstalk during C. elegans vulval development. PLoS Comput. Biol. 2007, 3:e92.
34. Hornberg J.J., et al. Cancer: a systems biology disease. Biosystems 2006, 83:81-90.
35. Taniguchi C.M., et al. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
36. Torkamani A., Schork N.J. Identification of rare cancer driver mutations by network reconstruction. Genome Res. 2009, 19:1570-1578.
37. Kim D., et al. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways. Oncogene 2007, 26:4571-4579.
38. Korcsmáros T., et al. How to design multi-target drugs: target search options in cellular networks. Expert Opin. Drug Discov. 2007, 2:1-10.
39. Kumar N., et al. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Mol. Pharmacol. 2008, 73:1668-1678.
40. Korcsmáros T., et al. Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery. Bioinformatics 2010, 26:2042-2050.
41. Haney S., et al. Ultrasensitive responses and specificity in cell signaling. BMC Syst. Biol. 2010, 4:119.
42. Behnia R., Munro S. Organelle identity and the signposts for membrane traffic. Nature 2005, 438:597-604.
43. Wen L., et al. Appl1 is essential for the survival of Xenopus pancreas, duodenum, and stomach progenitor cells. Dev. Dyn. 2010, 239:2198-2207.
44. Xin X., et al. APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E103-E110.
45. Shim J.-H., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19:2668-2681.
46. Prasad T.S.K., et al. Human Protein Reference Database - 2009 update. Nucleic Acids Res. 2009, 37:D767-D772.
47. The Gene Ontology Consortium The Gene Ontology: enhancements for 2011. Nucleic Acids Res. 2012, 40:D559-D564.
48. Stark C., et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res. 2011, 39:D698-D704.
49. Szklarczyk D., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39:D561-D568.
50. Stelzl U., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
51. Tang Y., et al. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the β1-adrenergic receptor. Proc. Natl Acad. Sci. U.S.A. 1999, 96:12559-12564.
52. Soubeyran P., et al. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 2002, 416:183-187.
53. Yam J.W.P., et al. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood 2004, 103:1445-1453.
54. Colland F., et al. Functional proteomics mapping of a human signaling pathway. Genome Res. 2004, 7:1324-1332.
55. Fiset A., et al. Compartmentalized CDK2 is connected with SHP-1 and β-catenin and regulates insulin internalization. Cell. Signal. 2011, 23:911-919.
56. Rashid S., et al. Endosomal adaptor proteins APPL1 and APPL2 are novel activators of β-catenin/TCF-mediated transcription. J. Biol. Chem. 2009, 284:18115-18128.
57. Zhang M., et al. Smad3 prevents β-catenin degradation and facilitates β-catenin nuclear translocation in chondrocytes. J. Biol. Chem. 2010, 285:8703-8710.
58. Kholodenko B.N., et al. Signalling ballet in space and time. Nat. Rev. Mol. Cell Biol. 2010, 11:414-426.
59. Bashor C.J., et al. Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics. Science 2008, 319:1539-1543.
60. Lim W.A. Designing customized cell signalling circuits. Nat. Rev. Mol. Cell Biol. 2010, 11:393-403.
61. Gould G.W., Lippincott-Schwartz J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat. Rev. Mol. Cell Biol. 2009, 10:287-292.
62. Wang Y., et al. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol. Cell. Biol. 2002, 22:7279-7290.
63. Murphy J.E., et al. Endosomes: a legitimate platform for the signaling train. Proc. Natl Acad. Sci. U.S.A. 2009, 106:17615-17622.
64. Ascano M., et al. Endocytic trafficking of neurotrophins in neural development. Trends Cell Biol. 2012, 22:266-273.
65. Schütze S., et al. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 2008, 9:655-662.
66. German C.L., et al. The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures. Exp. Cell Res. 2011, 317:1955-1969.
67. Xu F., et al. Live cell imaging of interleukin-6-induced targeting of " transcription factor" STAT3 to sequestering endosomes in the cytoplasm. Am. J Physiol. Cell Physiol. 2007, 293:C1374-C1382.
68. Ohba Y., et al. Spatiotemporal regulation of MyD88 - IRF-7 signalling for robust type-I interferon induction. Nature 2005, 2:1-6.
69. Kermorgant S., Parker P.J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 2008, 182:855-863.
70. Huang H.-R., et al. Endocytic pathway is required for Drosophila Toll innate immune signaling. Proc. Natl Acad. Sci. U.S.A. 2010, 107:8322-8327.
71. Devergne O., et al. The endocytic control of JAK/STAT signalling in Drosophila. J. Cell Sci. 2007, 120:3457-3464.
72. Vidal O.M., et al. Negative regulation of Drosophila JAK-STAT signalling by endocytic trafficking. J. Cell Sci. 2010, 123:3457-3466.
73. Bohn G., et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat. Med. 2007, 13:38-45.
74. Bronfman F.C., et al. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 2007, 67:1183-1203.
75. Lanzetti L., Di Fiore P.P. Endocytosis and cancer: an " insider" network with dangerous liaisons. Traffic 2008, 9:2011-2021.
76. Yu L., et al. Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential. Clin. Exp. Metastasis 1999, 17:213-219.
77. Fukui K., et al. Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol. Res. 2007, 37:957-965.
78. Tanaka N., et al. Endosomal sorting complex required for transport proteins in cancer pathogenesis, vesicular transport, and non-endosomal functions. Cancer Sci. 2008, 99:1293-1303.
79. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8:603-612.
80. Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell Biol. 2008, 9:99-111.
81. Michell R.H., et al. Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem. Sci. 2006, 31:52-63.
82. Ramírez F., Albrecht M. Finding scaffold proteins in interactomes. Trends Cell Biol. 2010, 20:2-4.
83. Punta M., et al. The Pfam protein families database. Nucleic Acids Res. 2012, 40:D290-D301.
84. Dimmer E.C., et al. The UniProt-GO Annotation database in 2011. Nucleic Acids Res. 2012, 40:D565-D570.
85. Farkas I.J., et al. Linking proteins to signaling pathways for experiment design and evaluation. PLoS ONE 2012, 7:e36202.
86. Kanehisa M., et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012, 40:D109-D114.
87. Croft D., et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011, 39:D691-D697.
88. Miaczynska M., Bar-Sagi D. Signaling endosomes: seeing is believing. Curr. Opin. Cell Biol. 2010, 22:535-540.